Personalis outlines $70M–$80M revenue target for 2025 amid 59% sequential clinical test growth and revised biopharma outlook Personalis outlines $70M–$80M revenue target for 2025 amid 59% sequential clinical test growth and revised biopharma outlook Post ContentpsnlRead More You might also be interested in reading Can Barry Silbert Delay the Inevitable?. August 6, 2025 In Mainstream ← Previous post Next post →